NCT02730403View on ClinicalTrials.gov

TAU Opioid Use Outcomes Following Discharge From Detoxification and Short Term Residential Programs Affiliated With CTN-0051

CompletedOBSERVATIONAL

Enrollment

211

Participants

Timeline

Start Date

June 1, 2016

Primary Completion Date

January 30, 2017

Study Completion Date

January 30, 2017

Conditions

Opioid Use Disorder

Interventions

OTHER

Treatment As Usual

Trial Locations (5)

10016

Bellevue Hospital, New York

32201

Gateway Community Services, Inc., Jacksonville

43207

Maryhaven, Columbus

91356

Tarzana Treatment Centers, Tarzana

02720

Stanley Street Treatment and Resources, Fall River

All Listed Sponsors

lead

NYU Langone Health

OTHER

NCT02730403 - TAU Opioid Use Outcomes Following Discharge From Detoxification and Short Term Residential Programs Affiliated With CTN-0051 | Biotech Hunter | Biotech Hunter